We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generic Drug Co. Can't Kill Merck IP Suit Over Antifungal

Law360, Los Angeles (October 31, 2016, 4:26 PM EDT) -- A New Jersey federal judge ruled Monday that Merck & Co. Inc. has a valid patent covering fungal infection treatment Cancidas, allowing a patent infringement suit the drug giant lodged against...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.